Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-16-495280
Filing Date
2016-03-07
Accepted
2016-03-07 16:31:28
Documents
4
Effectiveness Date
2016-03-07

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d155038ds8.htm S-8 42683
2 EX-5.1 d155038dex51.htm EX-5.1 10790
3 EX-23.1 d155038dex231.htm EX-23.1 1331
4 GRAPHIC g155038g05a55.jpg GRAPHIC 8371
  Complete submission text file 0001193125-16-495280.txt   67424
Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-209992 | Film No.: 161488869
SIC: 2834 Pharmaceutical Preparations